Skip to main content

Press Releases

Press Release RSS Feed (opens in new window)
Press release year list 2022 2021 2020 2019 2018 2017 2016
07/12/2022
Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug
06/06/2022
Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory Update
05/31/2022
Tetra Bio-Pharma Announces Voting Results of 2022 Annual General and Special Meeting
05/30/2022
Tetra Bio-Pharma Appoints Chief Financial Officer
05/18/2022
Tetra Bio-Pharma Receives EMA Orphan Drug Designation for a Novel Topical Therapeutic Containing CBD
05/17/2022
Tetra Bio-Pharma Announces Closing of First Tranche with Cannvalate
05/10/2022
Tetra Bio-Pharma Announces Licensing Agreement with True North for Patented CBD Technology
05/05/2022
Tetra Bio-Pharma and Cannvalate Enter Into Partnership
03/17/2022
Tetra Bio-Pharma's QIXLEEF™ on Track After Type C Meeting with U.S. FDA
03/08/2022
Tetra Bio-Pharma Provides Update on Research Collaboration with the University of Montreal Hospital Research Centre for Inhaled CBD
02/28/2022
Tetra Bio-Pharma Provides Management Update
02/22/2022
Tetra Bio-Pharma Signs License Agreement with Thorne for a Prebiotic Dietary Supplement
02/16/2022
Tetra Bio-Pharma Receives $4.5M from the Ministère de l'Économie et de l'Innovation/Investissement Québec
02/16/2022
Tetra Bio-Pharma reçoit un appui financier de 4,5 M$ du ministère de l'Économie et de l'Innovation/Investissement Québec
02/14/2022
Tetra Bio-Pharma Enters into a Strategic Partnership with Avicanna